Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition

被引:15
|
作者
Adamek, Rebecca N. [1 ]
Credille, Cy V. [1 ]
Dick, Benjamin L. [1 ]
Cohen, Seth M. [1 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92093 USA
来源
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY | 2018年 / 23卷 / 07期
关键词
Fragment-based drug discovery; Hydroxypyridinethione; Inhibitor; Isostere; Metal-binding pharmacophore; Metalloenzyme; MATRIX-METALLOPROTEINASE INHIBITORS; ZINC-BINDING GROUPS; SOFT ACIDS; DISCOVERY; IDENTIFICATION; RECOGNITION; SELECTIVITY; ENVIRONMENT; PYRITHIONE; SOLUBILITY;
D O I
10.1007/s00775-018-1593-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hydroxypyridinethiones (HOPTOs) are strong ligands for metal ions and potentially useful pharmacophores for inhibiting metalloenzymes relevant to human disease. However, HOPTOs have been sparingly used in drug discovery efforts due, in part, to concerns that this scaffold will act as apromiscuous, non-selective metalloenzyme inhibitor, as well as possesspoor pharmacokinetics (PK), which may undermine drug candidates containing this functional group. To advance HOPTOs as a useful pharmacophore for metalloenzyme inhibitors, a library of 22 HOPTO isostere compounds has been synthesized and investigated. This library demonstrates that it is possible to maintain the core metal-binding pharmacophore (MBP) while generating diversity in structure, electronics, and PK properties. This HOPTO library has been screened against a set of four different metalloenzymes, demonstrating that while the same metal-binding donor atoms are maintained, there is a wide range of activity between metalloenzyme targets. Overall, this work shows that HOPTO isosteres are useful MBPs and valuable scaffolds for metalloenzyme inhibitors.
引用
收藏
页码:1129 / 1138
页数:10
相关论文
共 50 条
  • [1] Isosteres of hydroxypyridinethione as drug-like pharmacophores for metalloenzyme inhibition
    Rebecca N. Adamek
    Cy V. Credille
    Benjamin L. Dick
    Seth M. Cohen
    JBIC Journal of Biological Inorganic Chemistry, 2018, 23 : 1129 - 1138
  • [2] Salicylate metal-binding isosteres as fragments for metalloenzyme inhibition
    Jackl, Moritz K.
    Seo, Hyeonglim
    Karges, Johannes
    Kalaj, Mark
    Cohen, Seth M.
    CHEMICAL SCIENCE, 2022, 13 (07) : 2128 - 2136
  • [3] DrugMint: a webserver for predicting and designing of drug-like molecules
    Dhanda, Sandeep Kumar
    Singla, Deepak
    Mondal, Alok K.
    Raghava, Gajendra P. S.
    BIOLOGY DIRECT, 2013, 8
  • [4] Drug-Like Property Concepts in Pharmaceutical Design
    Di, Li
    Kerns, Edward H.
    Carter, Guy T.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (19) : 2184 - 2194
  • [5] Late-stage Functionalization for Improving Drug-like Molecular Properties
    Castellino, Nathan J.
    Montgomery, Andrew P.
    Danon, Jonathan J.
    Kassiou, Michael
    CHEMICAL REVIEWS, 2023, 123 (13) : 8127 - 8153
  • [6] Explore drug-like space with deep generative models
    Wang, Jianmin
    Mao, Jiashun
    Wang, Meng
    Le, Xiangyang
    Wang, Yunyun
    METHODS, 2023, 210 : 52 - 59
  • [7] Carnosine derivatives: new multifunctional drug-like molecules
    Bellia, Francesco
    Vecchio, Graziella
    Rizzarelli, Enrico
    AMINO ACIDS, 2012, 43 (01) : 153 - 163
  • [8] In vitro and in silico exploration of IL-2 inhibition by small drug-like molecules
    Kalsoom, Saima
    Rashid, Umer
    Shaukat, Awais
    Abdalla, Omer Mohamed
    Hussain, Khalida
    Khan, Waqasuddin
    Nazir, Samina
    Mesaik, Mohammad Ahmad
    ul-Haq, Zaheer
    Ansari, Farzana Latif
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (12) : 5739 - 5751
  • [9] QSAR-based solubility model for drug-like compounds
    Gozalbes, Rafael
    Pineda-Lucena, Antonio
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (19) : 7078 - 7084
  • [10] Known drug space as a metric in exploring the boundaries of drug-like chemical space
    Mirza, Amin
    Desai, Radha
    Reynisson, Johannes
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (12) : 5006 - 5011